— Know what they know.
Not Investment Advice

COSM NASDAQ

Cosmos Health Inc.
1W: +8.1% 1M: +69.4% 3M: +40.8% YTD: -26.2% 1Y: -65.5% 3Y: -77.0% 5Y: -92.0%
$0.38
-0.01 (-1.58%)
 
Weekly Expected Move ±14.9%
$0 $0 $0 $0 $0
NASDAQ · Healthcare · Medical - Pharmaceuticals · Tech Score Buy · Power 61 · $20.7M mcap · 32M float · 24.47% daily turnover · Short 48% of daily vol
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$20.7M
52W Range0.1616-1.32
Volume2,462,128
Avg Volume7,947,809
Beta4.17
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOGrigorios Siokas
Employees163
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2010-07-23
5 Agiou Georgiou Str, Pilea
Thessaloniki, IL 55438
GR
312 536 3102
About Cosmos Health Inc.

Cosmos Health Inc. functions as a vertically integrated pharmaceutical firm, providing its own line of branded and generic medicines, nutraceuticals, non-prescription drugs, healthcare and infant products, medical devices, and various other goods. These are distributed via its established channels and an e-commerce marketplace. The company actively seeks, obtains, develops, and commercializes solutions designed to improve patients' well-being and health outcomes. Supporting these operations, it maintains distribution centers in both Greece and the United Kingdom, alongside a dedicated warehousing facility. Its clientele includes wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was established in 2009 and has its headquarters in Chicago, Illinois.

Recent Insider Trades

NameTypeSharesPriceDate
Siokas Grigorios P-Purchase 349,825 $0.20 2026-07-30
Siokas Grigorios P-Purchase 766,284 $0.18 2026-07-29
Terzis Georgios A-Award 328,407 $0.18 2026-07-29
Terzis Georgios P-Purchase 168,135 $0.25 2026-06-16
Siokas Grigorios P-Purchase 218,447 $0.21 2026-06-11

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms